Retevmo 00002-6120
Generic: Selpercatinib
Product NDC
00002-6120- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Tablet, Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 10, 2024
- Listing Expires
- December 31, 2026
- Application
- NDA218160
Need to source Retevmo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Selpercatinib | 120 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Packaging Options(1)
60 TABLET, COATED in 1 BOTTLE (0002-6120-60)